The role of FGF-signaling in early neural specification of human embryonic stem cells  by Cohen, Malkiel A. et al.
Developmental Biology 340 (2010) 450–458
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyThe role of FGF-signaling in early neural speciﬁcation of human embryonic stem cells
Malkiel A. Cohen a, Pavel Itsykson a, Benjamin E. Reubinoff a,b,⁎
a The Hadassah Human Embryonic Stem Cell Research Center, The Goldyne Savad Institute of Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Israel
b The Department of Gynecology, Hadassah Hebrew University Medical Center, Jerusalem, Israel⁎ Corresponding author. The Hadassah Human Embry
The Goldyne Savad Institute of Gene Therapy, Hadassah M
Jerusalem 91120, Israel.
E-mail address: benjaminr@ekmd.huji.ac.il (B.E. Reu
0012-1606/$ – see front matter © 2010 Elsevier Inc. A
doi:10.1016/j.ydbio.2010.01.030a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 4 August 2009
Revised 23 December 2009
Accepted 26 January 2010
Available online 10 February 2010
Keywords:
Human embryonic stem cells
Neural induction
FGF-signaling
Erk1/2 signaling
Primitive ectodermThe mechanisms that govern human neural speciﬁcation are not completely characterized. Here we used
human embryonic stem cells (hESCs) to study the role of ﬁbroblast growth factor (FGF)-signaling in early
human neural speciﬁcation. Differentiation was obtained by culturing clusters of hESCs in chemically-
deﬁned medium. We show that FGF-signaling, which is endogenously active during early differentiation of
hESCs, induces early neural speciﬁcation, while its blockage inhibits neuralization. The early neuralization
effect of FGF-signaling is not mediated by promoting the proliferation of existing neural precursors (NPs) or
prevention of their apoptosis. The neural instructive effect of FGF-signaling occurs after an initial FGF-
independent differentiation into primitive ectoderm-like fate. We further show that FGF-signaling can
induce neuralization by a mechanism which is independent of modulating bone morphogenic protein
(BMP)-signaling. Still, FGF-signaling is not essential for hESC neuralization which can occur in the absence of
FGF and BMP-signaling. Collectively, our data suggest that human neural induction is instructed by FGF-
signaling, though neuralization of hESCs can occur in its absence.onic Stem Cell Research Center,
edical Center, P.O. Box 12000,
binoff).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The induction of neural tissue represents a fundamental step in the
generation of the vertebrate nervous system. Early studies in Xenopus
embryos suggested that the nascent ectoderm receives an instructive
signal from theorganizer, a specialized groupof dorsalmesodermal cells,
which directs it to adopt a neural fate (Spemann and Mangold, 1924).
These data set the foundation for the classical model of neuralization,
suggesting that organizer's signals direct the ectoderm towards
neuralization, while in their absence, an epidermal fate is adopted.
Subsequent studies have indicated that the signals of the organizer
do not directly instruct neuralization, and that the organizer-secreted
molecules Noggin, Chordin, and Follistatin exert potent neuralizing
effects (Hemmati-Brivanlou et al., 1994; Lamb et al., 1993; Sasai et al.,
1995; Smith and Harland, 1992) by binding BMPs, which inhibit
neural and promote epidermal differentiation (Fainsod et al., 1997;
Piccolo et al., 1996; Zimmerman et al., 1996). These ﬁndings led to the
‘default model’ of neural induction, which proposes that ectodermal
cells have an autonomous tendency to differentiate into neural tissue
(Hemmati-Brivanlou and Melton, 1997).
A variety of studies in chick embryos have challenged the idea that
the activity of BMP-antagonists is sufﬁcient to induce neuralization,and suggested that FGF-signaling has a key role in early neural
differentiation (reviewed in Stern, 2005; Wilson and Edlund, 2001). It
was found that FGFs can induce acquisition of neural identity when
they are ectopically expressed in vivo. In addition, in some
experimental systems, neural induction is inhibited when FGF activity
is disrupted (Bertrand et al., 2003; Hongo et al., 1999; Kengaku and
Okamoto, 1993; Koshida et al., 2002; Lamb and Harland, 1995; Launay
et al., 1996; Streit et al., 2000; Wilson et al., 2000).
FGFs were suggested to exert their neuralizing effect through
inhibition of BMP-signaling either by phosphorylation of Smad1,
(Kuroda et al., 2005) or by repressing the expression of genes involved
in BMP-signaling (Koshida et al., 2002; Wilson et al., 2000).
Alternatively, recent experiments in various animal models suggested
that FGF-signaling directs neural differentiation via a BMP-indepen-
dent mechanism (Delaune et al., 2005; Kudoh et al., 2004; Wilson
et al., 2001).
In mammals, neuralization of mouse single ESCs was suggested to
be independent of FGF-signaling (Smukler et al., 2006; Tropepe et al.,
2001). However, others suggested that neural induction of mouse
ESCs (mESCs) is not a simple default pathway but depends on
autocrine FGF-signaling (Kunath et al., 2007; Pollard et al., 2008; Ying
et al., 2003b). Furthermore, it was shown that extracellularly-
regulated kinases 1 and 2 (Erk1/2) activity mediates the neuralizing
effect of FGF-signaling via a BMP-independent mechanism (Stavridis
et al., 2007).
Human ESCs may serve as a model to address these mechanisms
during human neurogenesis. For this purpose, we induce differen-
tiation of hESC clusters in chemically-deﬁned suspension culture
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system that noggin signiﬁcantly enhances the differentiation into NPs,
probably by suppressing the differentiation into lineages other than
the neural fate (Itsykson et al., 2005). Similar results were shown in
other differentiation culture systems of hESCs (Chambers et al., 2009;
Gerrard et al., 2005). Moreover, a recent study reported that hESCs
have an intrinsic capability to inhibit BMP-signaling at multiple levels
of the BMP cascade during neutralization (Lavaute et al., 2009).
Here, we further use our differentiation system to elucidate the
role of FGF-signaling in early neural commitment of hESCs. We show
that FGF-signaling has a role in inducing early neural speciﬁcation.
Moreover, the effect of FGF is probably mediated, at least in part,
independent of modulating BMP-signaling. Still, in line with the
‘default’ model, FGFs are not essential for neuralization of hESCs,
which can occur in the absence of FGF and BMP-signaling. In
summary, our data support an instructive role of FGF-signaling in
human neural speciﬁcation.Materials and methods
Cell culture
Cell culture, immunostaining, and ﬂuorescence activated cell
sorting (FACS) analysis were performed as previously described
(Cohen et al., 2007). Brieﬂy, hESCs with normal karyotypes (46XX)
were cultured up to 10 passages on human foreskin feeders in
KnockOut DMEM supplemented with 14% KnockOut Serum Replace-
ment, 1 mM L-glutamine, 1% nonessential amino acids, 50 U/ml
penicillin and 50 μg/ml streptomycin (all from Invitrogen Corp.,
Carlsbad, CA). Colonies of hESCs were dislodged 7 days after passage
using Collagenase IV (Invitrogen) into small clusters that were
randomly allocated to suspension culture in CDM comprised of
DMEM/F12 (1:1), 2% B27, 2 mM L-glutamine, 50 U/ml penicillin,
50 μg/ml streptomycin (Invitrogen), with or without rh-basic-FGF
(bFGF; FGF-2; 20 ng/ml), rm-noggin (500 ng/ml; R&D Systems Inc.,
Minneapolis, MN), SU5402 (5 μM), U0126 (10 μM; Calbiochem,
Darmstadt, Germany). SU5402 and U0126 were dissolved in DMSO
(Sigma, St. Louis, MO), and the ﬁnal concentration of DMSO in CDM
was 0.01%. DMSO at this concentration did not have an effect on
neural differentiation of hESC cluster (Supplementary Fig. S1).Immunoﬂuorescence staining
Cell clusters were dissociated, plated on laminin (1–24 h), and
ﬁxed in 4% PFA. 0.2% Triton X-100 or 0.1% saponin (Sigma) were used
for membrane permeabilization. Cells were incubated with anti-
human-Oct-4 (1:50, IgG2b; Santa-Cruz Biotechnology, Inc., Santa-
Cruz, CA), human-SSEA-4 (1:100, IgG3; Chemicon, Temecula, CA),
polysialic acid (PSA) neural cell adhesion molecule (NCAM; 1:200;
IgM; Chemicon), Cytokeratin-8 (1:1; IgG: Becton-Dickinson, San-Jose,
CA), human-FGFR1 (Flg; 1:100; Santa-Cruz), human-Nestin (1:200,
Chemicon), Musashi1 (1:100, Chemicon), β-tubulin-III (1:2000,
IgG2b; Sigma), and PCNA (Proliferating Cell Nuclear Antigen; Rb
IgG, 1:200, Bethyl Laboratories, Montgomery, TX). Secondary anti-
bodies: ﬂuorescein-isothiocyanate (FITC)-conjugated goat anti-
mouse (1:20; Dako, Glostrup, Denmark) and donkey anti-mouse
IgM (1:100; Jackson Immunoresearch Laboratories, Inc., West Grove,
PA) antibodies, Texas Red-conjugated goat anti-rabbit or Rhodamine
Red-conjugated donkey anti-rabbit (1:200; Jackson) antibodies.
Specimens were mounted with medium containing 4′,6-diamidino-
2-phenylindole (DAPI; Vector Laboratories Inc., Burlingame, CA) and
visualized with ﬂuorescent (E600; Nikon, Kanagawa, Japan) or
confocal microscopes (Fluoview; Olympus, Melville, NY). For quan-
titative analysis, 200 cells were scored in 4 random ﬁelds.FACS analysis
Cells were dissociated, incubated with anti-SSEA-3 (1:100, rat
IgM; Chemicon), or anti-SSEA-4 or anti-PSA-NCAM antibodies. For
Oct-4 detection, hESCs were ﬁxed with 100% ethanol (−20 °C,
15 min) and incubated with anti-Oct-4 (1:20). Secondary antibodies:
FITC-conjugated goat anti-mouse (1:100; Dako), allophycocyanin
(APC)-conjugated goat anti-mouse (1:500) or R-phycoerythrin (R-
PE)-conjugated mouse anti-rat IgM (1:50; Southern Biotech Associ-
ates, Inc. Birmingham, AL). For survival assays, following incubation
with anti-PSA-NCAM and APC-conjugated goat anti-mouse, cells were
further stained for AnnexinV using the MEBCYTO kit (MBL, Woburn,
MA). 20,000 live cells were acquired with the FACSCalibur system
(Becton-Dickinson) and analyzed with FCS-Expresses software (De-
Novo software, LA, CA).
Western blotting
Whole cell lysates (50 μg) were electrophoresed on 3–10%
gradient SDS-PAGE gels and transferred to polyvinylidene-ﬂuoride
(PVDF) membranes (Bio-Rad Laboratories, Hercules, CA). The blots
were probed with anti-Erk2 (1:1000, Santa-Cruz), anti-double
phosphorylated (dp)-Erk1/2 (1:4000, Sigma), and anti-β-actin
(1:10,000, Sigma) antibodies. Membranes were then probed with
peroxidase-conjugated secondary antibody (1:5000; Jackson Immu-
noresearch Laboratories, Inc) and processed with ECL (Thermo-
Scientiﬁc, Rockford, IL).
Reverse transcriptase (RT) and quantitative polymerase chain reaction
(qPCR) analysis
Total RNA was isolated using TRIzol reagent (Invitrogen) and
reverse transcribed by M-MLV-RT with random primers (Promega,
Madison, WI). Each sample was treated with DNA-free DNase
(Applied Biosystems, Foster City, CA). TaqMan qPCR assays were
used on a 7900HT cycler (Applied Biosystems). Gene expres-
sions threshold-cycle values were normalized to endogenous levels
of GusB.
Population doubling time
hESC clusters were cultured in suspension in 12-well plates. Cell
clusters from each well were collected, dissociated, the number of
cells per well was counted and the average number of cells per well
was calculated in days 0, 4 and 7 of differentiation. The average count
numbers were plotted as cells/well against time (days). Population
doubling time was analyzed by regression curve analysis using an
exponential series.
Statistical analysis
Data are presented as mean±SEM. Statistical signiﬁcance was
determined by Student's t-test.
Results
hESCs (HES1 and HES2 lines (Reubinoff et al., 2000)) were
cultured on mitotically-inactivated human foreskin-ﬁbroblasts.
Since foreskin-ﬁbroblasts secrete bFGF (Eiselleova et al., 2008),
supplementation of bFGF was not required to sustain undifferentiated
proliferation of the hESCs. To ensure that the cells maintained a
pluripotent phenotype under these culture conditions, we analyzed
the expression of markers of undifferentiated stem cells after at least 5
passages. FACS analysis and immunostaining demonstrated that
above 94.9% of the cells expressed markers of undifferentiated
pluripotent stem cells, including SSEA-3, SSEA-4, and Oct-4; 89±
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1.6±0.4% expressed PSA-NCAM (CD56), which is a marker of early
NPs (Figs. 1A–C and Supplementary Fig. S2A) (Carpenter et al., 2001;
Perrier et al., 2004). Thus, the starting cell populations that were used
to study neural differentiationwere relatively homogeneous andwere
comprised mainly of undifferentiated hESCs.
To induce differentiation, small hESC colonies were removed from
the feeders and cultured 14 days as free-ﬂoating clusters in a
chemically-deﬁned medium (CDM). The clusters gradually acquired
a morphology characteristic of cystic embryoid-bodies (Fig. 2H). 73±
5.6% of the cells within the clusters expressed PSA-NCAM while
26.3±1.1% expressed CK-8, which is not expressed by neural cells
(Fig. 2G and Supplementary Fig. S2D). Among variousmarkers of earlyFig. 1. The phenotype of hESCs andmodulation of FGF-signaling in their differentiated progen
of HES-1 cells express SSEA-4, SSEA-3, Oct-4 and CK-8, while minute percentage express PSA
(D) Immunoﬂuorescence staining of undifferentiated hESCs co-expressing Oct-4 and FGFR1
7 days of differentiation in CDM. After 3h of treatment with the inhibitors U0126 and SU54NPs, PSA-NCAMwas the ﬁrst to appear (Fig. 2A), as shown in hESCs by
others (Carpenter et al., 2001; Perrier et al., 2004) and therefore PSA-
NCAM was further used to identify neural differentiation.
We initially conﬁrmed that under our culture conditions, undif-
ferentiated as well as differentiating hESCs express molecules along
the FGF signal-transduction pathway. Immunostaining showed that
Oct-4+ undifferentiated hESCs co-expressed FGF-receptor-1 (FGFR1;
Fig. 1D). In addition, western blot analysis showed high levels of dp-
Erk1/2, suggesting active FGF-signaling within undifferentiated
hESCs, as reported by others (Kunath et al., 2007; Stavridis et al.,
2007). Furthermore, double phosphorylation of Erk1/2 was also
demonstrated during hESCs differentiation, within hESC clusters after
1 week of suspension culture (Fig. 1E).y. Representative FACS analysis (A) and immunostaining (B) showing that the majority
-NCAM. (C) A histogram summarizing the results from four independent experiments.
. (E) Western blot analysis of the level of dp-Erk1/2 in hESCs, and in hESC clusters after
02, a dose-dependent decrease in the levels of dp-Erk1/2 is evident. Scale bars 100 μM.
Fig. 2. FGF-signalingpromotes theneuralizationofhESCs.Histogrampresentationof the analysis ofmarkersof undifferentiatedHES-1hESCsandNPsderived fromthembyFACS (Oct-4, SSEA-
3 and PSA-NCAM) and immunostaining (Musashi, Nestin and β-tubulin-III) during 3 weeks of differentiation in CDM is presented in (A). Histogram presentation of the percentage of HES-1
cells expressing PSA-NCAMand CK-8 after 4 (B), 7 (D) and 14 (G) days of differentiation in CDM, CDM supplementedwith bFGF, U0126 or SU5402. qPCR analysis of the expression of neural
markers at 4 days of differentiation in thevarious conditions (C). Immunostainingwith anti-PSA-NCAM(E), CK-8 andNestin (F) of dissociated cells fromclusters after 7 days of differentiation
in the presence of bFGF. Dark-ﬁeld stereomicroscopic images of clusters after 14 days of differentiation in the absence (H) or presence (I) of bFGF. *Pb0.05; **Pb0.01; Scale bars 100 μM.
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Fig. 3. The effect of FGF-signaling on proliferation and apoptosis. The percentage of
proliferating NPs co-expressing PSA-NCAM and PCNA at days 4, 5, 6 and 7 of
differentiation in CDM, CDM supplemented with bFGF or U0126 (A). FACS analysis of
the percentage of AnexinV+ cells after 7 days of differentiation in the various culture
conditions is presented in (B). The percentage of AnexinV+ cells was analyzed in the
fraction of PSA-NCAM+ neural and the PSA-NCAM− non-neural cells. *Pb0.05.
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supplementing themedium either with bFGF or two inhibitors of FGF-
signaling: the FGFR1-TK-activity inhibitor, SU5402 (Mohammadi
et al., 1997) and the mitogen activated protein kinase kinases 1 and
2 (MEK1/2) inhibitor, U0126 (Favata et al., 1998). We studied the
effect of U0126, which blocks the Erk1/2 pathway, since it was shown
in the mESC system that FGF-induced Erk1/2 signaling is required for
neural speciﬁcation (Stavridis et al., 2007). We determined the
minimal concentration of the inhibitors that effectively blocked FGF-
signaling, as monitored by the level of dp-Erk1/2 (Fig. 1E). These
concentrations were further used along the study.
Profound differences in cluster-morphology were observed when
differentiation was induced in the presence of exogenous bFGF, as
compared to its absence. In the presence of bFGF, clusters were
denser, round, and opaque, did not develop cystic structures, and
resembled neural spheres (Figs. 2H–I). After 14 days of differentiation
in the presence of bFGF, the percentage of PSA-NCAM+ NPs was
increased to 89.1±0.5% while only 7.3±0.4% expressed CK-8,
suggesting that bFGF signiﬁcantly (Pb0.05) augmented the differen-
tiation to NPs (Fig. 2G).Whenwe blocked FGF-signaling by U0126 and
SU5402, the percentage of cells expressing PSA-NCAM was signiﬁ-
cantly (Pb0.05, Pb0.01; respectively) reduced compared to control
cultures (Fig. 2G and Supplementary Fig. S2D). Under these condi-
tions, themajority of cells expressed CK-8 (Fig. 2G and Supplementary
Fig. S2D), while the expression of markers of pluripotency was down-
regulated, (Supplementary Fig. S3) suggesting differentiation towards
non-neural lineages. Thus, in the absence of exogenous and endo-
genous FGF activity, neural differentiation was minimal.
The high percentage of NPs at 14 days, in the presence of bFGF,
could be related to a neural inductive effect of FGFs, a mitogenic effect
(Itsykson et al., 2005), or to the promotion of survival of NPs. To
further analyze the effect of FGFs and to determine its timing, we
characterized the process of neural differentiation at 4 and 7 days.
At 4 days of differentiation, the percentage of PSA-NCAM+ NPs
was minimal (b1.9%) and not affected by bFGF or FGF-inhibitors
supplementation (Fig. 2B and Supplementary Fig. S2B). Furthermore,
qPCR analysis showed that exogenous bFGF and blockage of FGF-
signaling did not signiﬁcantly alter the expression of transcripts of
early neural genes (Fig. 2C). Regarding proliferation, the percentage of
PCNA expressing cells within the population of PSA-NCAM+ NPs was
not altered by modulating FGF-signaling (Fig. 3A). These data
suggested that at 4 days of differentiation, FGFs had neither a
signiﬁcant mitogenic effect nor a neural inductive one.
At 7 days of differentiation, the percentage of NPs was profoundly
increased to 73.6±0.6% in the presence of bFGF supplementation. It
was minimal in the presence of FGF-signaling inhibitors (2.2±0.5%
and 2.6±0.8% with U0126 and SU5402, respectively), while 55±0.8%
of the cells differentiated into NPs in CDM, in the absence of
exogenous bFGF reﬂecting the neural inducing effect of endogenous
FGF-signaling (Figs. 2D–F and Supplementary Fig. S2C). We sought to
determine whether the profound increase in the percentage of NPs
from days 4 to 7 was related to an inductive or mitogenic effect of
FGFs.
To address this issuewe determined the doubling time during days
4–7 in the presence and absence of FGF-signaling. The doubling time
was 2.35±0.15 days in the presence of bFGF, 2.58±0.36 days in
CDM and was not signiﬁcantly different with U0126 supplementation
(2.71±0.37 days). The similar doubling time between days 4 and 7, in
the presence and absence of FGF-signaling suggested that the
profound neuralizing effect of FGF-signaling during this time period
could not be attributed to a mitogenic effect.
To further address this issue we evaluated the percentage of
proliferating NPs, as determined by analyzing the expression of PCNA
within PSA-NCAM expressing cells, between days 4 and 7. The
percentages of proliferating NPs were similar in days 4, 5 and 6 when
differentiation occurred in the presence of exogenous bFGF, U0126 orin CDM, suggesting that FGF-signaling did not have a mitogenic effect
on the NPs during this time period. At day 7, a mild but still signiﬁcant
increase in the percentage of proliferating NPs was observed in the
presence of FGF-signaling (61.7±1.3% in CDM supplemented with
bFGF and 59.1±1.4% in CDM) compared to its absence (42.9±2.1% in
the presence of U0126: Fig 3A). Given the 2.4 day doubling time of the
cells between days 4 and 7 in the presence of exogenous FGF, the
mitogenic effect of FGF-signaling at day 7 could only have a marginal
contribution to the profound neuralization at this time period.
We further determined whether FGF-signaling augments neur-
alization by promoting the survival of NPs. At 7 days, the percentage
of AnexinV+ apoptotic cells among PSA-NCAM+ NPs was similar to
the percentage among non-neural cells (PSA-NCAM−) and both were
not altered by modulating FGF-signaling (Fig. 3B). Thus FGFs did not
promote the survival of NPs. Since the profound neuralization
between days 4 and 7 could not be related to promotion of
proliferation or survival, our data suggest that FGF-signaling have a
neural inductive effect, which is initiated after 4 days of differentia-
tion of free-ﬂoating hESC clusters.
To further support the role of FGFs in inducing neuralization
between days 4 and 7 and the lack of their effect during the ﬁrst 4 days
of differentiation, we performed perturbation studies. The differen-
tiating hESC clusters were treated either for 4 days with SU5402
followed by 3 days of bFGF, or the opposite: ﬁrst 4 days with bFGF,
followed by 3 days of SU5402. Control clusters were treated 7 days
with either SU5402 or bFGF. FACS analysis showed that the
percentage of NPs expressing PSA-NCAM, and its mean ﬂuorescence
intensity (MFI) was low in hESC clusters treated during days 5–7 with
SU5402, and was similar to the measurements in clusters after 7 days
of treatment with the inhibitor. Moreover, the FACS parameters were
similar in hESC clusters that were treated 7 days with bFGF, and those
treated by SU5402 during the ﬁrst 4 days followed by bFGF during
days 5–7. These results further support our ﬁnding that FGF-signaling
induces neuralization during days 4–7 of differentiation (Fig. 4A).
Accumulating data support the role of FGF-signaling in promoting
pluripotency of hESCs (Xu et al., 2008), while here we demonstrate its
role in inducing neuralization between days 4 and 7. To further study
this shift from promoting pluripotency to inducing neuralization, we
Fig. 4. hESC clusters differentiate initially into primitive ectoderm in an FGF-independent process, which is followed by FGF-directed neuralization. (A) FACS analysis of the fraction
of PSA-NCAM+ cells (gray) and their mean ﬂuorescence intensity (MFI; white) after 7 days of differentiation in the presence of various combinations of bFGF and SU5402 as
indicated. The data was normalized against the same measurements in HES1-clusters after 7 days of differentiation in the presence of bFGF. (B) qPCR analysis of the expression of
markers of primitive ectoderm (Fgf5 and PRCE) and ICM (Rex1) in undifferentiated HES-1 cells, after 4 days of differentiation in the absence (CDM) and presence of bFGF, and after
7 days of differentiation in the presence of bFGF. (C) qPCR analysis of the expression of primitive ectoderm markers after 4 days of differentiation in the presence of FGF-inhibitors.
*Pb0.05.
455M.A. Cohen et al. / Developmental Biology 340 (2010) 450–458characterized the differentiation process and its dependence on FGF-
signaling during the initial 4 days of suspension culture. qPCR analysis
showed that the expression of markers of primitive ectoderm
(Rathjen and Rathjen, 2003; Rodda et al., 2002) was up-regulated
after 4 days of differentiation. Concomitantly, the expression of the
inner cell mass (ICM) marker Rex1 (Rodda et al., 2002; Toyooka et al.,
2008) was down-regulated, suggesting that differentiation towards
primitive ectoderm-like fate occurred at day 4 (Fig. 4B). Moreover, the
expression of markers of primitive ectoderm at day 4 was not affected
by inhibiting FGF-signaling (Fig. 4C). These results suggest that under
our suspension culture conditions, FGF-signaling cannot prevent and
does not have a signiﬁcant role in the early process of differentiation
into primitive ectoderm.
Recent reports in animal models suggest that FGF-signaling may
direct neural differentiation via a BMP-independent mechanism
(Delaune et al., 2005; Kudoh et al., 2004; Stavridis et al., 2007;
Wilson et al., 2001). We therefore determined whether a similar
mechanismmay mediate, at least in part, the neural inducing effect of
FGF-signaling on hESCs. To study a potential BMP-independent effect
of FGFs, we blocked BMP-signaling by noggin. In the presence of BMP-signaling blockage, the percentage of NPs was minimal and
unchanged at 4 days of differentiation and was signiﬁcantly aug-
mented at 7 days (Pb0.01; Fig. 5A) (Itsykson et al., 2005). When we
further inhibited FGF-signaling in addition to the block in BMP-
signaling, an increase in the percentage of PSA-NCAM+ NPs was still
observed at 7 days. However, the percentage of NPs at day 7 was
signiﬁcantly lower in the presence of noggin plus U0126 compared to
noggin alone. This reduction in the percentage of NPs upon the
addition of U0126 to noggin reﬂected the inhibition of neuralizing
effect of endogenous FGF-signaling which occurred when BMP-
signaling was blocked (marked in Fig. 5A and Supplementary
Fig. S4A). These results further support the neural instructive effect
of FGF-signaling and suggest that FGF-signaling can induce neuraliza-
tion of hESCs through a mechanism which is independent of modu-
lation of BMP-signaling.
Using the same experimental approach, we next determined
whether FGF-signaling is essential for neuralization. After 4 days of
differentiation in the presence of noggin, the expression levels of
transcripts of three early neural markers were signiﬁcantly up-
regulated compared to the levels in control clusters differentiating in
Fig. 5. Neural speciﬁcation of hESCs occurs in the absence of FGF- and BMP-signaling. (A) Histogram of the percentage of PSA-NCAM+ and CK-8+ cells after 4 and 7 days of
differentiation of HES-1 clusters in CDM, CDM supplemented with noggin or noggin plus U0126. (B) qPCR analysis of the expression of neural markers after 4 days of
differentiation in the presence of noggin, and noggin plus FGF-inhibitors. (C) The percentages of PSA-NCAM+ and CK-8+ cells after 14 days of differentiation in the same conditions
as in (B). *Pb0.05; **Pb0.01.
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expression levels of the transcripts of early neural markers were still
up-regulated, but to a lesser extent (the augmentation of Pax6
expression was signiﬁcantly lower, NeuroD1 and Musashi were not
up-regulated in the presence of U0126 and SU5402, respectively;
Fig. 5B). Along the same line, 21.35±1.55% andmore than 45.8±2.3%
of the cells expressed PSA-NCAM after 7 and 14 days, respectively, of
differentiation in the presence of noggin and U0126 (Figs. 5A, C and
Supplementary Fig. S4), suggesting that FGF-signaling was not
required for early neuralization when BMP-signaling was blocked.
Still, as noted above, endogenous FGF-signaling profoundly augment-
ed the process of neuralization in the presence of noggin (Fig. 5 and
Supplementary Fig. S4). Thus, when BMP-signaling was blocked, FGF-
signaling was not essential for neuralization, though it still promoted
the tendency for neuralization (Fig. 6).
Discussion
In this studywe show that FGFs induce early neural speciﬁcation of
hESCs, after an initial FGF-independent differentiation into primitive
ectoderm-like fate. The neural inductive effect of FGF-signaling is
mediated at least in part by a mechanism which is independent of
modulating BMP-signaling. Still, neuralization occurs in the absence of
FGF and BMP-signaling, suggesting that FGFs are not essential for
neural differentiation of hESCs.
To allow the dissection of the events that occur during early
human neuralization, we used a simple single-step differentiation
approach within a deﬁned serum- and feeder-free suspension culture
system. Cultures of undifferentiated hESCs show various levels of
background differentiation under standard feeder-dependent culture
conditions (Adewumi et al., 2007). To avoid bias of the results due topre-existing differentiated cells, we conﬁrmed that the starting
population of cells was homogenous and mainly comprised of
undifferentiated hESCs.
In our differentiation system, after 4 days, hESCs initially differ-
entiated into a primitive ectoderm-like fate as indicated by down-
regulation of the expression of the ICM marker Rex1 and up-
regulation of Fgf5 and PRCE (Espl1) (Rathjen and Rathjen, 2003;
Rodda et al., 2002; Toyooka et al., 2008). A similar initial step of
differentiation of hESCs into primitive ectoderm within 3–6 days was
also reported by others using different differentiation conditions
(Bajpai et al., 2009; Chambers et al., 2009; Pankratz et al., 2007). This
initial step was unaffected by modulating FGF-signaling, suggesting
that the initial differentiation of hESCs into primitive ectoderm was
independent of FGFs.
A similar initial step of differentiation into a primitive ectoderm-
like fate was also demonstrated in mESCs (Stavridis et al., 2007).
There are signiﬁcant differences between human and mouse ESCs
with regard to marker expression and signaling pathways that
promote pluripotency and differentiation. While BMP and LIF
signaling promote pluripotency in the mouse system (Ying et al.,
2003a, 2008), TGF-β and FGF-signaling play a major role in hESCs
(Vallier et al., 2005; Xu et al., 2008). Interestingly, both in the human
and mouse systems (Stavridis et al., 2007), differentiation into a
primitive ectoderm-like state occurs when FGF-signaling is blocked.
Our data suggest that FGF-signaling promoted the differentiation
form the stage of primitive ectoderm to the early NP stage. We
showed that promotion of proliferation of pre-existing NPs or
prevention of their apoptosis could not mediate the neuralizing effect
of FGF. The neural inductive effect of FGF-signaling in hESCs is in line
with its proposed neuralizing effect in early development of other
species (Bertrand et al., 2003; Hongo et al., 1999; Kengaku and
Fig. 6. Early neural differentiation events in hESC clusters— the role of FGF. Floating hESC clusters differentiate towards the primitive ectoderm lineage independent of FGF-signaling.
Further neuralization is instructed by FGF-signaling. FGF-signaling induces neuralization, at least in part, through a mechanism which is independent of inhibition of BMP-signaling.
In line with the default model, inhibition of BMP-signaling promotes neuralization of hESCs. FGF-signaling encourages the neuralization tendency in the presence of noggin, though it
is not essential, since neuralization still occurs when both BMP and FGF-signaling are blocked.
457M.A. Cohen et al. / Developmental Biology 340 (2010) 450–458Okamoto, 1993; Koshida et al., 2002; Lamb and Harland, 1995; Launay
et al., 1996; Stern, 2005; Streit et al., 2000; Wilson and Edlund, 2001;
Wilson et al., 2000). FGF-induced neuralization was blocked when we
inhibited MEK1/2 suggesting that active Erk1/2 signaling pathway
was essential for the FGF neuralization effect. These results are in line
with the reported requirement for active Erk1/2 signaling for FGF-
induced neural speciﬁcation in mESCs (Stavridis et al., 2007).
FGF-signaling has diverse roles during development depending on
the temporal and spatial states (Mason, 2007). While FGF-signaling
was shown to promote the maintenance of undifferentiated hESCs
(Vallier et al., 2005; Xu et al., 2008), we demonstrate its role in
promoting neural differentiation of hESCs. This dual effect can
probably occur, given our results showing FGF-independent differ-
entiation from hESCs into a primitive ectoderm fate, clarifying the
potential of FGFs to promote hESC pluripotency on one hand and to
promote neural differentiation at a subsequent stage of primitive
ectoderm differentiation on the other hand (Fig. 6). In mESCs and
chick embryos FGFwas also shown to exert its neuralizing effect at the
primitive ectoderm stage (Stavridis et al., 2007).
In the presence of noggin, which blocks BMP-signaling, we showed
that inhibition of Erk1/2 signaling reduced the percentage of NPs after
7 days of differentiation. This reduction probably reﬂected the
inhibition of a BMP-independent neuralizing effect of endogenous
Erk1/2 signaling. Reports in various animal models suggest that FGF-
signaling directs neural differentiation via a BMP-independent
mechanism (Delaune et al., 2005; Kudoh et al., 2004; Stavridis et al.,
2007; Wilson et al., 2001). In line with this notion, a recent study in
hESCs revoked the suggested neuralizing effect of FGFs through the
inhibition of BMP-signaling by phosphorylation of Smad1 (Lavaute
et al., 2009). Similarly, our results indicate that the effect of FGF on the
neuralization of hESCs, at least in part, was not mediated through
modulation of BMP-signaling.
While our data support the inductive role of FGF-signaling in
neural speciﬁcation of hESCs, both in the presence and block of BMP-
signaling, we also show that FGFs are not essential for neuralization
of hESCs. In the presence of inhibition of BMP and FGF-signaling,
neural differentiation still occurred. Similar results were reported
with single mESCs in suspension, which also gave rise to neural cellsin the absence of FGF-signaling (Smukler et al., 2006). These ﬁndings
are in line with the ‘default’ model of neuralization in amphibians
(Hemmati-Brivanlou and Melton, 1997).
bFGF is used in protocols for neural induction of hESCs (Bajpai
et al., 2009; Cohen et al., 2007; Li and Zhang, 2006). Here we
characterized, for the ﬁrst time, its role and time of action during early
neural differentiation of hESCs. Furthermore, in our simple, deﬁned
single-step differentiation approach, by using bFGF as a single
differentiation inducing factor, 90% of the cells expressed the early
neural marker PSA-NCAM within 2 weeks of differentiation. Thus, we
show that bFGF can efﬁciently induce neural differentiation of hESCs
and may be used to augment the derivation of NPs from hESCs.
In conclusion, our data suggest that hESCs differentiate into a
primitive ectoderm-like fate independent of FGF-signaling, while
further neural differentiation is instructed by FGF-signaling. Still, in
the presence of BMP antagonism there is a tendency for neuralization
which is independent of FGFs but is promoted by their signaling
(Fig. 6).
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